Oncologix Tech, Inc.
OCLG
$0.0001
$0.000.00%
OTC PK
05/31/2015 | |||||
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 316.96% | ||||
Total Receivables | 13.92% | ||||
Inventory | 0.00% | ||||
Prepaid Expenses | 50.76% | ||||
Finance Division Loans and Leases Current | -- | ||||
Total Finance Division Other Current Assets | -- | ||||
Other Current Assets | -- | ||||
Total Current Assets | 20.63% | ||||
|
|||||
Total Current Assets | 20.63% | ||||
Net Property, Plant & Equipment | -7.12% | ||||
Long-term Investments | 0.00% | ||||
Goodwill | 0.00% | ||||
Total Other Intangibles | -7.01% | ||||
Finance Div Loans & Leases LT | -- | ||||
Total Finance Div Other LT Assets | -- | ||||
Total Other Assets | 33.73% | ||||
Total Assets | 6.65% | ||||
|
|||||
Total Accounts Payable | 5.52% | ||||
Total Accrued Expenses | 4.66% | ||||
Short-term Debt | 15.63% | ||||
Current Portion of Long-Term Debt/Capital Leases | -- | ||||
Finance Division Debt Current | -48.01% | ||||
Total Finance Division Other Current Liabilities | 6.40% | ||||
Total Other Current Liabilities | 6.40% | ||||
Total Current Liabilities | 7.37% | ||||
|
|||||
Total Current Liabilities | 7.37% | ||||
Long-Term Debt | -6.19% | ||||
Short-term Debt | 15.63% | ||||
Capital Leases | -- | ||||
Finance Division Debt Non Current | -- | ||||
Total Finance Division Other Non Current Liabilities | -- | ||||
Total Other Liabilities | -- | ||||
Total Liabilities | 6.23% | ||||
|
|||||
Common Stock & APIC | 1.02% | ||||
Retained Earnings | -1.06% | ||||
Treasury Stock & Other | -- | ||||
Total Common Equity | -4.87% | ||||
|
|||||
Preferred Stock Redeemable | -- | ||||
Preferred Stock Non Redeemable | -- | ||||
Preferred Stock Convertible | 0.00% | ||||
Preferred Stock, Others | -- | ||||
Total Preferred Equity | 0.00% | ||||
|
|||||
Total Common Equity | -4.87% | ||||
Total Preferred Equity | 0.00% | ||||
Total Minority Interest | -- | ||||
Total Equity | -4.87% | ||||
|